
About Swiss Rockets
Swiss Rockets is a Healthcare company based in Basel (Switzerland) founded in 2018. Swiss Rockets has completed 1 acquisition, including Complete Genomics. Swiss Rockets offers products and services including Incubator Services and Accelerator Services. Its focus areas include Traditional Medical Devices. Its legal entity is Swiss Rockets AG.
Company details
Incubator and accelerator for biotech startups. This entity identifies, invests in, and cultivates promising biotech ventures. Services include mentorship, funding, access to resources, legal and regulatory guidance, and a network of industry experts. The focus is on accelerating growth and achieving goals for portfolio companies, providing financial resources and expertise in drug discovery, development, manufacturing, and regulatory affairs. Support extends to business and management topics, legal and IT support, market access, financing, and business development. The goal is to foster innovation and improve patient outcomes.
- Headquarters Basel, Switzerland
- SectorsHealthcare
- Website swissrockets.com
- Social LinkedIn Facebook Instagram
- Legal Name Swiss Rockets Ag
- Investors
- Investments & Acquisitions
Products & Services of Swiss Rockets
Swiss Rockets offers a comprehensive portfolio of products and services, including Incubator Services and Accelerator Services.
Access to scientific experts, facilities, and resources for biotech startups is provided to support early-stage development.
Financial resources, mentorship, and guidance on business and management topics are offered to accelerate the growth of biotech companies.
Funding Insights of Swiss Rockets
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Swiss Rockets with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | Seed | β | β |
1 investors in total: 1 institutional.
Investors in Swiss Rockets
Swiss Rockets has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Emergent BioSolutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Vaccines for viral infections are developed by the company. | 1998 | emergentbiosolutions.com | Gaithersburg, United States |
Investor details for Swiss Rockets
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Swiss Rockets
8 people are tracked at Swiss Rockets (6 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Milan Crnogorac | Chief Technology Officer | Leadership |
Dr. Vladimir Cmiljanovic | Founder, Chairman And CEO Of Swiss Rockets AG | Leadership |
Ivana Cmiljanovic | Head Of Digital Marketing | Leadership |
Michel Petignat | Head Of Human Resources | Leadership |
Doriano Fabbro | Chief Scientific Officer | Leadership |
Andreas Emmenegger | Group CFO And Group CBO | Leadership |
Albert Muntane Casanova | Senior Advisor | Team |
Selim Celebi | Finance And Accounting Specialist | Team |
Complete people profiles for Swiss Rockets
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Swiss Rockets
Swiss Rockets has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Complete Genomics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
DNA sequencing platform for human genome analysis is developed. | completegenomics.com | San Jose, United States | 2006 | Feb 2026 | β’β’β’β’ |
Complete acquisition details for Swiss Rockets
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Swiss Rockets
3 dated milestones of Swiss Rockets across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Swiss Rockets is founded.
- Funding First funding round.
- Acquisition Acquires Complete Genomics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Swiss Rockets
Swiss Rockets was founded in 2018 and raised its 1st funding round 7 years after it was founded.
Swiss Rockets is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Incubator and accelerator for biotech startups. This entity identifies, invests in, and cultivates promising biotech ventures. Services include mentorship, funding, access to resources, legal and regulatory guidance, and a network of industry experts. The focus is on accelerating growth and achieving goals for portfolio companies, providing financial resources and expertise in drug discovery, development, manufacturing, and regulatory affairs. Support extends to business and management topics, legal and IT support, market access, financing, and business development. The goal is to foster innovation and improve patient outcomes.
Swiss Rockets offers Incubator Services and Accelerator Services.
Swiss Rockets has made 1 acquisition, including Complete Genomics.
Swiss Rockets has 1 investor. Key investors include Emergent BioSolutions.
Swiss Rockets operates through Swiss Rockets Ag.